Based on RNA-Seq data upon ILK targeting in cisplatin-resistant ovarian cancer cells and survival analysis of differentially expressed genes, ACTL6B, ANKRD22, ARHGAP23, BSN, CAMKV, CHGA, COL13A1, ILK, LTF, MAPK8IP2, MARVELD3, NKAIN1, NMNAT2, PAX5, SAG, SEMA3G, SLC4A8, SLC5A1, and VGF were selected for further validation by SYBR Green-based qRT-PCR analysis. This evidence concerns the gene ILK and ovarian carcinoma.